Your browser doesn't support javascript.
loading
Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment.
Zhang, Bin; Wang, Ning; Zhang, Cunlong; Gao, Chunmei; Zhang, Wei; Chen, Kang; Wu, Weibin; Chen, Yuzong; Tan, Chunyan; Liu, Feng; Jiang, Yuyang.
Afiliación
  • Zhang B; Department of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China; Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen, 518057, PR China.
  • Wang N; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China.
  • Zhang C; Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen, 518057, PR China.
  • Gao C; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China. Electronic address: chunmeigao@sz.tsinghua.edu.cn.
  • Zhang W; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China.
  • Chen K; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China.
  • Wu W; Department of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China; Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen, 518057, PR China.
  • Chen Y; Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen, 518057, PR China; Bioinformatics and Drug Design Group, Department of Pharmacy, Centre for Computational Science and Engineering, National University of Singapore, 117543, Singapore.
  • Tan C; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China.
  • Liu F; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China.
  • Jiang Y; Department of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China; National & Local United Engineering Lab for Personalized Anti-tumor Drugs, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, PR China; Department of Pharmacol
Eur J Med Chem ; 129: 337-348, 2017 Mar 31.
Article en En | MEDLINE | ID: mdl-28237663
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Proteínas Inhibidoras de la Apoptosis / Acridonas / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Med Chem Año: 2017 Tipo del documento: Article Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Proteínas Inhibidoras de la Apoptosis / Acridonas / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Med Chem Año: 2017 Tipo del documento: Article Pais de publicación: Francia